NASDAQ: AVXL

Anavex Life Sciences Corp.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL) resulting from allegations that Anavex may have issued materially misleading business information to the investing public.

If you purchased Anavex securities and would like to join the prospective action, please click “Join This Class Action.”

Retainer Agreement
See Full Details
Join This Class Action
If you purchased Anavex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

Before the market opened on February 1, 2022, Anavex Life Sciences Corp. announced that a phase 3 trial of ANAVEX2-73 (blarcamesine) for Rett syndrome met primary and secondary endpoints. Following the announcement, several people on social media indicated that the primary and secondary endpoints were recently changed. STAT’s Adam Feuerstein tweeted, “Anavex changed the primary and secondary endpoints of this Rett study on Jan. 18, allowing it to claim success when the drug most likely failed.”

Shares of Anavex Life Sciences Corp stock dropped 16% in intraday trading on February 1, 2022.

Follow us on:
Twitter
Company Name: Anavex Life Sciences Corp.
Stock Symbol: AVXL
Class Period: N/A
Court: N/A
Share This Class Action
Join This Class Action

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Case Attorneys

Phillip Kim

New York, Philadelphia Metro

275 Madison Avenue
40th Floor
New York, NY 10016

Tel: (212) 686-1060
Privacy Policy | Accessibility
Scroll to Top